 | • レポートコード：QYR9N7817 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、薬物動態のグローバル市場について調査・分析したレポートで、種類別（非コンパートメントメソッド、コンパートメントメソッド）、用途別（腫瘍学、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・薬物動態の世界市場規模 ・主要企業別市場シェア ・薬物動態の世界市場規模：種類別（非コンパートメントメソッド、コンパートメントメソッド） ・薬物動態の世界市場規模：用途別（腫瘍学、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、その他） ・薬物動態のアメリカ市場規模（種類別、用途別） ・薬物動態のヨーロッパ市場規模（種類別、用途別） ・薬物動態の中国市場規模（種類別、用途別） ・薬物動態の日本市場規模（種類別、用途別） ・薬物動態の東南アジア市場規模（種類別、用途別） ・薬物動態のインド市場規模（種類別、用途別） ・薬物動態の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・薬物動態の世界市場予測（2019年-2025年） ・薬物動態の地域別市場予測（2019年-2025年） ... |
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body, and the effects and routes of excretion of the metabolites of the drug.
In 2018, the global Pharmacokinetics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pharmacokinetics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacokinetics development in United States, Europe and China.
The key players covered in this study
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Market segment by Type, the product can be split into
Noncompartmental Methods
Compartmental Methods
Market segment by Application, split into
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pharmacokinetics status, future forecast, growth opportunity, key market and key players.
To present the Pharmacokinetics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pharmacokinetics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacokinetics Market Size Growth Rate by Type (2014-2025)
1.4.2 Noncompartmental Methods
1.4.3 Compartmental Methods
1.5 Market by Application
1.5.1 Global Pharmacokinetics Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Cardiovascular Diseases
1.5.4 Infectious Diseases
1.5.5 Autoimmune Diseases
1.5.6 Respiratory Disorders
1.5.7 Neurological Disorders
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pharmacokinetics Market Size
2.2 Pharmacokinetics Growth Trends by Regions
2.2.1 Pharmacokinetics Market Size by Regions (2014-2025)
2.2.2 Pharmacokinetics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pharmacokinetics Market Size by Manufacturers
3.1.1 Global Pharmacokinetics Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmacokinetics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacokinetics Key Players Head office and Area Served
3.3 Key Players Pharmacokinetics Product/Solution/Service
3.4 Date of Enter into Pharmacokinetics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pharmacokinetics Market Size by Type (2014-2019)
4.2 Global Pharmacokinetics Market Size by Application (2014-2019)
5 United States
5.1 United States Pharmacokinetics Market Size (2014-2019)
5.2 Pharmacokinetics Key Players in United States
5.3 United States Pharmacokinetics Market Size by Type
5.4 United States Pharmacokinetics Market Size by Application
6 Europe
6.1 Europe Pharmacokinetics Market Size (2014-2019)
6.2 Pharmacokinetics Key Players in Europe
6.3 Europe Pharmacokinetics Market Size by Type
6.4 Europe Pharmacokinetics Market Size by Application
7 China
7.1 China Pharmacokinetics Market Size (2014-2019)
7.2 Pharmacokinetics Key Players in China
7.3 China Pharmacokinetics Market Size by Type
7.4 China Pharmacokinetics Market Size by Application
8 Japan
8.1 Japan Pharmacokinetics Market Size (2014-2019)
8.2 Pharmacokinetics Key Players in Japan
8.3 Japan Pharmacokinetics Market Size by Type
8.4 Japan Pharmacokinetics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pharmacokinetics Market Size (2014-2019)
9.2 Pharmacokinetics Key Players in Southeast Asia
9.3 Southeast Asia Pharmacokinetics Market Size by Type
9.4 Southeast Asia Pharmacokinetics Market Size by Application
10 India
10.1 India Pharmacokinetics Market Size (2014-2019)
10.2 Pharmacokinetics Key Players in India
10.3 India Pharmacokinetics Market Size by Type
10.4 India Pharmacokinetics Market Size by Application
11 Central & South America
11.1 Central & South America Pharmacokinetics Market Size (2014-2019)
11.2 Pharmacokinetics Key Players in Central & South America
11.3 Central & South America Pharmacokinetics Market Size by Type
11.4 Central & South America Pharmacokinetics Market Size by Application
12 International Players Profiles
12.1 Charles River Laboratories
12.1.1 Charles River Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacokinetics Introduction
12.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2014-2019)
12.1.5 Charles River Laboratories Recent Development
12.2 Covance
12.2.1 Covance Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacokinetics Introduction
12.2.4 Covance Revenue in Pharmacokinetics Business (2014-2019)
12.2.5 Covance Recent Development
12.3 Cyprotex
12.3.1 Cyprotex Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacokinetics Introduction
12.3.4 Cyprotex Revenue in Pharmacokinetics Business (2014-2019)
12.3.5 Cyprotex Recent Development
12.4 Drumetix Laboratories
12.4.1 Drumetix Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacokinetics Introduction
12.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2014-2019)
12.4.5 Drumetix Laboratories Recent Development
12.5 Eurofins Scientific
12.5.1 Eurofins Scientific Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacokinetics Introduction
12.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2014-2019)
12.5.5 Eurofins Scientific Recent Development
12.6 GVK Biosciences
12.6.1 GVK Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacokinetics Introduction
12.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2014-2019)
12.6.5 GVK Biosciences Recent Development
12.7 LGC
12.7.1 LGC Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacokinetics Introduction
12.7.4 LGC Revenue in Pharmacokinetics Business (2014-2019)
12.7.5 LGC Recent Development
12.8 Parexel
12.8.1 Parexel Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacokinetics Introduction
12.8.4 Parexel Revenue in Pharmacokinetics Business (2014-2019)
12.8.5 Parexel Recent Development
12.9 Pharmoptima
12.9.1 Pharmoptima Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmacokinetics Introduction
12.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2014-2019)
12.9.5 Pharmoptima Recent Development
12.10 TCG Lifesciences
12.10.1 TCG Lifesciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmacokinetics Introduction
12.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2014-2019)
12.10.5 TCG Lifesciences Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Pharmacokinetics Key Market Segments
Table Key Players Pharmacokinetics Covered
Table Global Pharmacokinetics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pharmacokinetics Market Size Market Share by Type 2014-2025
Figure Noncompartmental Methods Figures
Table Key Players of Noncompartmental Methods
Figure Compartmental Methods Figures
Table Key Players of Compartmental Methods
Table Global Pharmacokinetics Market Size Growth by Application 2014-2025 (Million US$)
Figure Oncology Case Studies
Figure Cardiovascular Diseases Case Studies
Figure Infectious Diseases Case Studies
Figure Autoimmune Diseases Case Studies
Figure Respiratory Disorders Case Studies
Figure Neurological Disorders Case Studies
Figure Others Case Studies
Figure Pharmacokinetics Report Years Considered
Table Global Pharmacokinetics Market Size 2014-2025 (Million US$)
Figure Global Pharmacokinetics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pharmacokinetics Market Size by Regions 2014-2025 (Million US$)
Table Global Pharmacokinetics Market Size by Regions 2014-2019 (Million US$)
Table Global Pharmacokinetics Market Share by Regions 2014-2019
Figure Global Pharmacokinetics Market Share by Regions 2014-2019
Figure Global Pharmacokinetics Market Share by Regions 2019
Table Market Top Trends
Table Global Pharmacokinetics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pharmacokinetics Market Share by Manufacturers (2014-2019)
Figure Global Pharmacokinetics Market Share by Manufacturers in 2018
Table Global Pharmacokinetics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pharmacokinetics Product/Solution/Service
Table Date of Enter into Pharmacokinetics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table Global Pharmacokinetics Market Size Share by Type (2014-2019)
Figure Global Pharmacokinetics Market Size Market Share by Type (2014-2019)
Table Global Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table Global Pharmacokinetics Market Size Share by Application (2014-2019)
Figure Global Pharmacokinetics Market Size Market Share by Application (2014-2019)
Figure Global Pharmacokinetics Revenue Market Share by Application in 2018
Figure United States Pharmacokinetics Market Size 2014-2019 (Million US$)
Table United States Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table United States Key Players Pharmacokinetics Market Share (2018-2019)
Table United States Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table United States Pharmacokinetics Market Share by Type (2014-2019)
Table United States Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table United States Pharmacokinetics Market Share by Application (2014-2019)
Figure Europe Pharmacokinetics Market Size 2014-2019 (Million US$)
Table Europe Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table Europe Key Players Pharmacokinetics Market Share (2018-2019)
Table Europe Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table Europe Pharmacokinetics Market Share by Type (2014-2019)
Table Europe Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table Europe Pharmacokinetics Market Share by Application (2014-2019)
Figure China Pharmacokinetics Market Size 2014-2019 (Million US$)
Table China Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table China Key Players Pharmacokinetics Market Share (2018-2019)
Table China Pharmacokinetics Market Size by Type (2014-20189) (Million US$)
Table China Pharmacokinetics Market Share by Type (2014-2019)
Table China Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table China Pharmacokinetics Market Share by Application (2014-2019)
Figure Japan Pharmacokinetics Market Size 2014-2019 (Million US$)
Table Japan Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table Japan Key Players Pharmacokinetics Market Share (2018-2019)
Table Japan Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table Japan Pharmacokinetics Market Share by Type (2014-2019)
Table Japan Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table Japan Pharmacokinetics Market Share by Application (2014-2019)
Figure Southeast Asia Pharmacokinetics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pharmacokinetics Market Share (2018-2019)
Table Southeast Asia Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pharmacokinetics Market Share by Type (2014-2019)
Table Southeast Asia Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pharmacokinetics Market Share by Application (2014-2019)
Figure India Pharmacokinetics Market Size 2014-2019 (Million US$)
Table India Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table India Key Players Pharmacokinetics Market Share (2018-2019)
Table India Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table India Pharmacokinetics Market Share by Type (2014-2019)
Table India Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table India Pharmacokinetics Market Share by Application (2014-2019)
Figure Central & South America Pharmacokinetics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pharmacokinetics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pharmacokinetics Market Share (2018-2019)
Table Central & South America Pharmacokinetics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pharmacokinetics Market Share by Type (2014-2019)
Table Central & South America Pharmacokinetics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pharmacokinetics Market Share by Application (2014-2019)
Table Charles River Laboratories Company Details
Table Charles River Laboratories Revenue in Pharmacokinetics Business (2014-2019) (Million US$)
Figure Charles River Laboratories Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Charles River Laboratories Recent Development
Table Covance Company Details
Table Covance Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Covance Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Covance Recent Development
Table Cyprotex Company Details
Table Cyprotex Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Cyprotex Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Cyprotex Recent Development
Table Drumetix Laboratories Company Details
Table Drumetix Laboratories Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Drumetix Laboratories Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Drumetix Laboratories Recent Development
Table Eurofins Scientific Company Details
Table Eurofins Scientific Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Eurofins Scientific Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Eurofins Scientific Recent Development
Table GVK Biosciences Company Details
Table GVK Biosciences Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure GVK Biosciences Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table GVK Biosciences Recent Development
Table LGC Company Details
Table LGC Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure LGC Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table LGC Recent Development
Table Parexel Company Details
Table Parexel Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Parexel Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Parexel Recent Development
Table Pharmoptima Company Details
Table Pharmoptima Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure Pharmoptima Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table Pharmoptima Recent Development
Table TCG Lifesciences Company Details
Table TCG Lifesciences Revenue in Pharmacokinetics Business (2014-2019)(Million US$)
Figure TCG Lifesciences Revenue Growth Rate in Pharmacokinetics Business (2014-2019)
Table TCG Lifesciences Recent Development
Table Global Pharmacokinetics Market Size by Regions (Million US$) 2019-2025
Figure Global Pharmacokinetics Market Size Share by Regions (2019-2025)
Figure Global Pharmacokinetics Market Size Share by Regions in 2025
Figure United States Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure China Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure India Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pharmacokinetics Market Size Forecast (2019-2025)(Million USD)
Table Global Pharmacokinetics Market Size by Product (2019-2025) (Million US$)
Figure Global Pharmacokinetics Market Size by Product (2019-2025)
Figure Global Pharmacokinetics Market Size by Product in 2025
Table Global Pharmacokinetics Market Size by Application (2019-2025) (Million US$)
Figure Global Pharmacokinetics Market Size by Application (2019-2025)
Figure Global Pharmacokinetics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の奇病市場：市場規模・現状・予測 An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…- 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
- 世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Treatment status, future forecast, growth opportuni…
- 世界の口腔疾患の治療市場：市場規模・現状・予測 Oral diseases ranging from cavities to cancer are all serious threats to your oral health.In 2018, the global Oral Diseases Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global …
- 世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測 Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Europe is estimated to be the domin…